Related Experiment Video
Updated: Jul 7, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
PSDTA: An Approach to Drug-Target Binding Affinity Prediction by Integrating Physicochemical and Structural
Shuang Wang1, Mao Li1, Peifu Han2,3
1Qingdao Institute of Software, College of Computer Science and Technology, China University of Petroleum (East China), Shandong Key Laboratory of Intelligent Oil Gas Industrial Software, Qingdao, Shandong266580, China.
Abstract:
Accurate prediction of drug-target binding affinity (DTA) is critical for repurposing. Although deep learning has been widely applied in this field, existing methods still face challenges, including inadequate integration of physicochemical properties and structural information, which leads to high feature redundancy and limited generalization performance. To address these challenges, we propose a DTA prediction method, PSDTA (where P represents physicochemical properties and S represents structural information), which integrates physicochemical properties into the initial feature representations. Unlike conventional approaches, PSDTA explicitly incorporates structural information on amino acids, thereby avoiding the risk of information leakage caused by directly using coordinates as features and enhancing the model's generalization capability. Furthermore, two complementary channels are designed to identify binding-relevant residues at both residue and group levels, thereby reducing feature redundancy. To evaluate its effectiveness, we conducted experiments on three benchmark data sets: PDBBind v2016, PDBBind v2020, and Davis. By comparing with several state-of-the-art algorithms, PSDTA achieves the best results in terms of performance. Interpretability analyses indicate that the two channels identify highly consistent and complementary binding-related regions.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamic Models: Overview
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
